 |
|
Re-186 hydroxyethylidene diphosphonate
An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labeled with the radioisotope rhenium Re 186. Re-186 hydroxyethylidene diphosphonate binds to hydroxyapatitie in bone, delivering a cytotoxic dose of beta radiation to primary and metastatic bone tumors. Re-186 is a beta emitter with a short half-life, a radioisotope profile that provides localized antitumor radiocytotoxicity while sparing extramedullary bone marrow tissues. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | 186Re-etidronate
Re 186 hydroxyethylidene diphosphonate
rhenium Re 186 etidronate
rhenium Re 186 etidronate
Rhenium-186 HEDP
rhenium-186 hydroxyethylidene diphosphonate | | | | Abbreviations: | | Re-186 HEDP
rhenium-186 HEDP | | |
| Previous: | ras peptide cancer vaccine, rasburicase, ravuconazole, RayGel, razoxane | | Next: | Rebetol, Rebif, rebimastat, Recentin, recombinant 70-kD heat-shock protein |
|
|
